Subcutaneous xenografted results showed that overexpressing RNF43 in RCC cells dramatically reduced the tumor size and mass when compared to the control group, while co-overexpressing RNF43 with miR-181d-5p could block the effects of RNF43 (Fig. 9G, H). Here, RNF43 is linked to neoplasm.